Investigational drug · Phase 3
Sovateltide
Also called: IRL-1620, PMZ-1620
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Traumatic Brain Injury, Acute Ischemic Stroke, Cerebral Stroke.
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
11
Any phase or sponsor naming "Sovateltide"
First trial start
2025
Jul 24, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Sovateltide", any sponsor or status.
Conditions studied
As listed on its trial records.
- Traumatic Brain Injury
- Acute Ischemic Stroke
- Cerebral Stroke
Approved drugs for the same conditions: Stroke prevention · Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "Sovateltide" as an intervention, largest first.
- Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic StrokePivotal-lookingRecruiting
Pharmazz, Inc.Industry
NCT05691244 · 514 participants (planned) · Start Jul 24, 2025 · Primary completion Sep 2027
Drug: Drug: Normal Saline; Sovateltide · For: Acute Ischemic Stroke; Cerebral Stroke
Sites: Tucson, Arizona; Carmichael, California; Oxnard, California · 57 sites in all
- Sovateltide for the Treatment of Acute Traumatic Brain InjuryPivotal-lookingNot yet recruiting
Pharmazz, Inc.Industry
NCT07861126 · 214 participants (planned) · Start Dec 2026 · Primary completion Feb 2028
Drug: Placebo; Sovateltide · For: Traumatic Brain Injury
- Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic StrokePivotal-lookingActive, not recruiting
Pharmazz, Inc.Industry
NCT05955326 · 160 participants (planned) · Start Jan 8, 2024 · Primary completion Dec 18, 2026
Drug: Sovateltide · For: Acute Cerebral Ischemia
Sites: Guntur, India; Amravati, India; Kota, India · 6 sites in all
- Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic StrokePivotal-lookingCompleted
Pharmazz, Inc.Industry
NCT04047563 · 158 participants · Start Nov 10, 2019 · Primary completion Feb 10, 2022
Drug: Normal Saline along with standard treatment; PMZ-1620 (sovateltide) along with standard treatment · For: Cerebral Ischemia; Cerebral Infarction; Stroke, Acute
Sites: Agra, India; Amravati, India; Chandigarh, India · 11 sites in all
Pharmazz, Inc.Industry
NCT04052737 · 80 participants · Start Mar 23, 2018 · Primary completion Dec 20, 2022
Drug: Normal Saline along with standard treatment; PMZ-1620 (sovateltide) along with standard treatment · For: Alzheimer Disease; Dementia
Sites: Chandigarh, India; Lucknow, India; Mumbai, India · 5 sites in all
Pharmazz, Inc.Industry
NCT05514340 · 40 participants (planned) · Start Sep 6, 2023 · Primary completion Nov 2026
Drug: Normal Saline along with standard treatment; Sovateltide along with standard treatment · For: Hypoxic-Ischemic Encephalopathy; Neonatal Asphyxia; Neonatal Encephalopathy
Sites: Mangalore, India; Ludhiana, India; Hyderabad, India · 4 sites in all
Pharmazz, Inc.Industry
NCT04046484 · 40 participants · Start Jan 19, 2018 · Primary completion Apr 12, 2019
Drug: Normal Saline along with standard treatment; PMZ-1620 along with standard treatment · For: Acute Stroke; Cerebral Ischemia
Sites: Gūrgaon, India; Hyderabad, India; Lucknow, India · 7 sites in all
Pharmazz, Inc.Industry
NCT04054414 · 40 participants (planned) · Start Jan 10, 2019 · Primary completion Jun 2026
Drug: Normal Saline along with standard treatment; PMZ-1620 along with standard treatment · For: Acute Spinal Cord Injury
Sites: Belagavi, India; Kolkata, India; Lucknow, India · 5 sites in all
Spectrum Pharmaceuticals, IncIndustry
NCT00613691 · 36 participants · Start Jan 2008 · Primary completion Jan 2012
Drug: SPI-1620 · For: Carcinoma
Sites: San Antonio, Texas
Spectrum Pharmaceuticals, IncIndustry
NCT01741155 · 34 participants · Start May 2013 · Primary completion Jul 2015
Drug: SPI-1620; Docetaxel · For: Non Small Cell Lung Cancer (NSCLC)
Sites: Cincinnati, Ohio; Chattanooga, Tennessee; Nashville, Tennessee · 5 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Sovateltide at the heart-brain axis crosstalk in Alzheimer's disease: a promising multi-target and cutting-edge therapeutic approach.
Kushawaha SK, Vashisht K, Kumar H, et al. · Inflammopharmacology 2026
- Real-world functional outcomes of sovateltide as an adjunct to standard therapy in acute ischemic stroke: A prospective observational study.
Kandasamy G, Selvaraj L, Orayj K, et al. · Medicine (Baltimore) 2026
- Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.
Davenport A, Anwar M, Kuc R, et al. · Can J Physiol Pharmacol 2026
- Efficacy and Safety of Sovateltide in Patients with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Clinical Trial.
Gulati A, Adwani SG, Vijaya P, et al. · Drugs 2024
- The Effects of IRL-1620 in Post-ischemic Brain Injury: A Systematic Review and Meta-analysis of Experimental Studies.
Moustakas D, Mani I, Pouliakis A, et al. · Neurocrit Care 2024
- Sovateltide (ILR-1620) Improves Motor Function and Reduces Hyperalgesia in a Rat Model of Spinal Cord Injury.
Mavridis T, Mavridi A, Karampela E, et al. · Neurocrit Care 2024
Also in development for Traumatic Brain Injury
- Autologous HB-adMSCsPhase 22 trials
Hope Biosciences LLC · Traumatic Brain Injury, Relapsing Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.